Life Technologies Scientist Uma Lakshmipathy presents, "Solving Challenges in the Generation of Induced Pluripotent …
By NEVAGiles23
Dr. Uma Lakshmipathy speaks at various conferences about work on the creation of integration-free induced pluripotent stem cells at high efficiency with Sendai Virus using the CytoTune™ -iPS Reprogramming Kit. Uma Lakshmipathy's next speaking engagement will be in Mid February at the Stem Cell Banking Conference in London.
Carlsbad, California (PRWEB) February 14, 2012
Uma's last presentation about the Generation of Induced Pluripotent Stem Cells summarized here was also recorded for viewing and placed on the Life Technologies website. (http://find.lifetechnologies.com/stemcells/umavideo/article)
The CytoTune™ – iPS Reprogramming Kit is a high efficiency, integration- free, easy-to-use somatic cell reprogramming kit used in the generation of induced pluripotent stem cells. This kit utilizes Sendai Virus particles of the four Yamanaka factors, which have been shown to be critical in the successful generation of induced pluripotent stem cells.
In her presentations, Uma Lakshmipathy discusses two current challenges faced when generating iPSC including low efficiency and expertise of users.
Low Efficiency
The most common method for generation of induced pluripotent stem cells is the transfection of the four Yamanaka factors using lentivirus or retrovirus. One of the biggest challenges for scientists right now is the low efficiency of iPSC generation. With difficult to transfect cell types or cells from older patients, efficiencies can be 0.001% or lower when using lentiviral or retroviral methods.
Expertise of Users
The second challenge is for users with little expertise that have a difficult time detecting these emerging iPSC colonies. When looking for pluripotent stem cells, people can either pick them up really easily or have trouble deciding what clones to place their bet on.
Efficiency & Safety of IPSC Generation
There are several methods which improve reprogramming efficiency including viral non-integrating and small molecule methods such as mRNA, microRNA and small molecules. The developers of the CytoTune™ -iPS Reprogramming Kit concentrated on a non-integrating viral method utilizing Sendai Virus, a negative sense RNA virus. Sendai Virus is able to infect a wide variety of cell types and generates induced pluripotent stem cells at efficiencies 100-fold higher than lentiviral or retroviral methods.
When comparing efficiency vs. safety of reprogramming methods, small molecules like microRNA, RNA and protein which don’t leave a footprint are safer for cell therapy research; however, the efficiency of generating induced pluripotent stem cells with these methods is pretty low at this point in time.
The highest efficiency so far has been achieved with viral methods such as Retrovirus and Lentivirus. More recently the CytoTune™ -iPS Reprogramming Kit actually exceeds the efficiency that can be obtained with these traditional viral systems and at the same time it is much safer because it is a non-integrating RNA virus. Therefore it will not leave a footprint in the iPSCs that are created.
The CytoTune™ -iPS Reprogramming Kit will:
Reduce hands on time – enables successful iPS reprogramming in one simple transduction Generate more cells – high efficiency reprogramming offers more iPS cells from a single experiment Use in a broad range of experiments – lack of genomic integration and viral remnants allows use from basic to clinical research
Ease of Use
The CytoTune™ -iPS Reprogramming Kit provides a simple system for somatic cell reprogramming. For most cell types, the CytoTune™ -iPS Reprogramming Kit requires only one application of the virus for successful cell reprogramming, unlike other methods such as Lentivirus and mRNA which can require multiple rounds of transduction to produce iPS cells. Selection of colonies is also easier with the CytoTune™ –iPS Reprogramming Kit due to the lower number of non-induced pluripotent stem cells that are generated.
To view this presentation visit http://find.lifetechnologies.com/stemcells/umavideo/article
Uma Lakshmipathy's protocol, “Transfection of Human Embryonic Stem Cells” can be seen here http://bit.ly/y91Gpd
###
Jennifer Hornstein
Life Technologies
(760) 602-4577
Email Information
Go here to read the rest:
URL: http://news.yahoo.com/life-technologies-scientist-uma-lakshmipathy-presents-solving-challenges-081356677.html
Related Post
- Improved adult-derived human stem cells have fewer genetic changes than expected - May 2nd, 2012
- How to Make a Broken Heart Mend Itself - April 29th, 2012
- VistaGen Secures Key U.S. Patent Covering Stem Cell Technology Methods Used to Test Drug Candidates for Liver Toxicity - April 25th, 2012
- IBN Discovers Human Neural Stem Cells, Promising Discovery For Breast Cancer Therapy - April 22nd, 2012
- IBN Discovers Human Neural Stem Cells with Tumor Targeting Ability - A Promising Discovery for Breast Cancer Therapy - April 22nd, 2012
- Scientists discover neural stem cells with tumour targeting ability - April 22nd, 2012
- Human neural stem cells with tumor targeting ability discovered - April 22nd, 2012
- :: 20, Apr 2012 :: IBN DISCOVERS HUMAN NEURAL STEM CELLS WITH TUMOR TARGETING ABILITY – A PROMISING DISCOVERY FOR ... - April 22nd, 2012
- Scientists discover tumor-targeting neural stem cells - April 22nd, 2012
- Cellular Dynamics Expands Distribution Agreement with iPS Academia Japan, Inc. to Include Distribution of iCell ... - March 28th, 2012
- New experimental technique can produce cells with specific functions - March 15th, 2012
- Gut Cells Turned To Insulin Factories - New Type l Diabetes Treatment - March 14th, 2012
- Study demonstrates cells can acquire new functions through transcriptional regulatory network - March 14th, 2012
- Columbia Researchers Find Potential Role for Gut Cells in Treating Type I Diabetes - March 12th, 2012
- A new approach to treating type I diabetes? Gut cells transformed into insulin factories - March 12th, 2012
- Gut cells transformed into insulin factories 'could help to treat type I diabetes' - March 12th, 2012
- New approach to treating type 1 diabetes? Transforming gut cells into insulin factories - March 12th, 2012
- Presentations at the Society of Toxicology Annual Meeting Demonstrate Superior Predictivity of Cellular Dynamics ... - March 8th, 2012
- albuterol adverse effects - Video - February 21st, 2012
- Horizon in new super-cell elite - February 16th, 2012
- Research and Markets: Primary and Stem Cells: Gene Transfer Technologies and Applications - February 15th, 2012
- Radiation treatment transforms breast cancer stem cells into new iBCSCs - February 15th, 2012
- Radiation therapy transforms breast cancer cells into cancer stem cells - February 14th, 2012
- Radiation treatment generates cancer stem cells from less aggressive breast cancer cells, study suggests - February 14th, 2012
- Radiation Treatment Generates Cancer Stem Cells from Less Aggressive Breast Cancer Cells - February 14th, 2012
- Radiation treatment transforms breast cancer cells into cancer stem cells - February 14th, 2012
- Uttar Pradesh govt sets up 2 member committee to resolve IPS-IAS dispute - February 6th, 2012
- EC transfers Basti Commissioner to pacify agitating IPS officers - February 6th, 2012
- “Wide-ranging applications for pluripotent stem cells” - February 2nd, 2012
- Skin cells turned into neural precusors, bypassing stem-cell stage - January 31st, 2012
- Researchers turn skin cells into neural precusors, bypassing stem-cell stage - January 31st, 2012
- Stanford scientists turn skin cells into neural precusors, bypassing stem-cell stage - January 31st, 2012
- Professor Alan Trounson - World focus on stem cell research - Video - January 27th, 2012
- Experts comment on successful stem cell therapy for blindness - January 25th, 2012
- First Patients Shown to Improve with Embryonic Stem Cells - January 24th, 2012
- Stem cell treatment improves eyesight - January 24th, 2012
- Food Matters: Advancements continue to be made in stem cell research - January 20th, 2012
- Parkinson's Disease: Advancing Stem Cell Therapies - 2011 CIRM Grantee Meeting - Video - January 20th, 2012
- Uni to research childhood cancers - January 9th, 2012
- Positive results from BioCryst's BCX4208 Phase 2b study on gout - January 9th, 2012
california , cytotune , generation , high-efficiency , presentations , sendai-virus , Stem Cells , transfection , virus 


February 14th, 2012